Partners In Investing

We look at various instruments that might be thought to protect your portfolio from an inflationary outcome, whether as an inflation hedge or as a store of value.

Ben Inker addresses some of the objections we hear from investors who are hesitant to join us in betting strongly on value today.

The remarkable selloff in the merger arbitrage space over the last month has led to compelling opportunity for long-term investors.

Learn more about the underlying causes of inflation and why we believe the recent upsurge in inflationary angst is likely much ado about nothing.

As we enter Q3, our valuation metrics for emerging debt are less compelling than they were at the beginning of the quarter. In this piece, we update our valuation charts and commentary.

The Asset Allocation and Usonian Japan Equity teams comment on opportunities in Japan and why Japan small value holds the top spot among equities in GMO’s 7-Year Asset Class Forecasts.

Has alpha become disproportionately important to beta? At GMO, we think it has. In fact, the forecasted potential return to alpha on our data is the highest we have observed in nearly 20 years.

Profitable trades never happen in a straight line. Growth may have beaten Value in June, but our Equity Dislocation thesis remains intact. Value still deserves to win, by a lot.